Prosecution Insights
Last updated: October 04, 2026

Yeditepe Universitesi

Technology area: Biotechnology & Pharmaceuticals

3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days

Portfolio Summary

3
Total Pending OAs
3
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
2
Medium (67%)
1
Easy (33%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (67%)
§112 only1 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
33% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
2
Business / Other
67% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KWON, JOHN SEUNGJAI 1 45.7% +19.3%
PRONZATI, GINA 1 66.7% +45.9%
ANTHOPOLOS, PETER 1 57.4% +58.8%

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
17273994 USE OF PLANT EXOSOMES FOR SHOWING MODULATING EFFECTS ON IMMUNE SYSTEM CELLS ANTHOPOLOS, PETER 3d overdue
18864037 USE OF SODIUM PENTABORATE PENTAHYDRATE AS A CHEMOTHERAPEUTIC AGENT KWON, JOHN SEUNGJAI —
18843330 METHOD AND CULTURE MEDIUM FORMULATION WHICH CAN BE USED TO OBTAIN MOTOR NEURONS FROM PLURIPOTENT STEM CELL-DERIVED NEUROMESODERMAL STEM CELLS PRONZATI, GINA —

Top Art Units

Art UnitApps
1611 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18864037 USE OF SODIUM PENTABORATE PENTAHYDRATE AS A CHEMOTHERAPEUTIC AGENT KWON, JOHN SEUNGJAI — §103 Non-Final OA — Pending Nov 08, 2024
18843330 METHOD AND CULTURE MEDIUM FORMULATION WHICH CAN BE USED TO OBTAIN MOTOR NEURONS FROM PLURIPOTENT STEM CELL-DERIVED NEUROMESODERMAL STEM CELLS PRONZATI, GINA — §112 Non-Final OA — Pending Sep 03, 2024
17273994 USE OF PLANT EXOSOMES FOR SHOWING MODULATING EFFECTS ON IMMUNE SYSTEM CELLS ANTHOPOLOS, PETER 1611 §103 Non-Final OA 3d overdue Pending Mar 05, 2021

Managing Yeditepe Universitesi's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month